CareDx (CDNA) general counsel has 997 shares withheld for tax obligations

Rhea-AI Filing Summary

CareDx, Inc. Secretary and General Counsel Jeffrey Adam Novack reported a routine tax-related share disposition. On this Form 4, 997 shares of common stock were withheld by the company to cover tax obligations tied to the vesting of restricted stock units, at a value of $29.25 per share. After this withholding, Novack directly holds 111,635 shares of CareDx common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Novack Jeffrey Adam

Role Secretary and General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	997	$29.25	$29K

Holdings After Transaction: Common Stock — 111,635 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 997 shares Withholding value per share: $29.25 per share Shares held after transaction: 111,635 shares

3 metrics

Shares withheld for taxes 997 shares Withheld to cover tax obligations on RSU vesting

Withholding value per share $29.25 per share Value used for tax-withholding disposition

Shares held after transaction 111,635 shares Direct CareDx common stock held by Novack after withholding

Key Terms

restricted stock units, tax withholding obligations, Form 4

3 terms

restricted stock units financial

"in connection with the issuance of shares upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer in order to satisfy certain tax withholding obligations"

Form 4 regulatory

"On this Form 4, 997 shares of common stock were withheld"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:02 PM Accepted by SEC EDGAR 07/02/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Novack Jeffrey Adam

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Secretary and General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		F		997(1)	D	$29.25	111,635	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

	/s/ Jeffrey Adam Novack	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CareDx (CDNA) report for Jeffrey Adam Novack?

CareDx reported that Jeffrey Adam Novack had 997 shares of common stock withheld. These shares covered tax obligations arising from the vesting of restricted stock units, rather than an open-market sale, and are recorded as a tax-withholding disposition on a Form 4 filing.

Was the CareDx (CDNA) Novack transaction an open-market sale of shares?

No, the transaction was not an open-market sale. The 997 shares of CareDx common stock were withheld by the company to satisfy tax withholding obligations triggered by restricted stock unit vesting, a routine administrative event recorded as a tax-withholding disposition.

How many CareDx (CDNA) shares does Jeffrey Adam Novack hold after this Form 4?

Following the tax-withholding disposition, Jeffrey Adam Novack directly holds 111,635 shares of CareDx common stock. This figure reflects his remaining position after 997 shares were withheld to cover taxes related to restricted stock unit vesting.

At what value were the withheld CareDx (CDNA) shares recorded for Novack?

The 997 shares withheld from Jeffrey Adam Novack were recorded at $29.25 per share. This per-share value is used to determine the amount applied toward satisfying his tax withholding obligations when his restricted stock units vested.

What was the purpose of the share withholding reported in CareDx (CDNA)’s Form 4?

The share withholding was used to satisfy certain tax withholding obligations. When Jeffrey Adam Novack’s restricted stock units vested, CareDx withheld 997 common shares at $29.25 per share instead of requiring a separate cash payment for the related tax liability.